Skip to main content

Table 3 Antibodies used for characterization of putative stem/progenitor cell populations within the BMC preparation

From: Safety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans

Antigen Conjugation Company Catalog# Clone
CD34 FITC BD-Biosciences 555820 581
CD45 PerCP BD-Biosciences 340665 2D1
CD133 PE Miltenyi biotech 130-080-801 AC133
CD271 APC Miltenyi biotech 130-091-884 ME20.4-1.H4